Prognostic value of androgen receptor and cathepsin D co-expression in non-metastatic triple-negative breast cancer and correlation with other biomarkers

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Prognostic value of androgen receptor and cathepsin D co-expression in non-metastatic triple-negative breast cancer and correlation with other biomarkers

【24h】

Prognostic value of androgen receptor and cathepsin D co-expression in non-metastatic triple-negative breast cancer and correlation with other biomarkers

机译：雄激素受体和组织蛋白酶D共表达在非转移性三重阴性乳腺癌中的预后价值及与其他生物标志物的相关性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
中文文献
专利

1. Prognostic value of androgen receptor and cathepsin D co-expression in non-metastatic triple-negative breast cancer and correlation with other biomarkers [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：雄激素受体和组织蛋白酶D共表达在非转移性三重阴性乳腺癌中的预后价值及与其他生物标志物的相关性
2. Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis [J] . LiZhang, ChengFang, XianqunXu, BioMed research international . 2015,第1期

机译：雄激素受体，EGFR和BRCA1作为三阴性乳腺癌中的生物标志物：一项荟萃分析
3. Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al [J] . Breast Cancer: Targets and Therapy . 2016,第1期

机译：雄激素受体表达在三阴性乳腺癌中的预后价值：个人经验和Collignon等人对“三阴性乳腺癌：治疗挑战和解决方案”的评论
4. Estrogen Receptor-Positive Breast Cancer: Traditional Prognostics, Molecular Pathology: A New Breast Cancer Taxonomy and 21st Century Personalized Prognostic and Predictive Assays [C] . Frederick L. Baehner International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy . 2009

机译：雌激素受体阳性乳腺癌：传统预测，分子病理：新的乳腺癌分类和21世纪个性化预测和预测测定
5. Extracellular Vesicles: Isolation with Multivalent Aptamers and Conferring Receptors to Triple-Negative Breast Cancer Cells for Targeted Drug Delivery [D] . Xue, Fei. 2022

机译：细胞外囊泡：用多价适体分离，并赋予三阴性乳腺癌细胞的受体进行靶向药物递送
6. Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers [O] . Séverine Guiu, Caroline Mollevi, Céline Charon-Barra, 2018

机译：雄激素受体和FOXA1共表达在非转移性三阴性乳腺癌中的预后价值及其与其他生物标志物的相关性
7. Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about ldquo;Triple-negative breast cancer: treatment challenges and solutionsrdquo; by Collignon et al [O] . Giovanni Tuccari, Antonio Ieni, Valeria Barresi, 2016

机译：三重阴性乳腺癌中雄激素受体表达的预后价值：个人经验和关于“三重阴性乳腺癌：治疗挑战和解决方案”的评论，Collignon等
8. Targeting Androgen Receptor in Breast Cancer: Enzalutamide as a Novel Breast Cancer Therapeutic. [R] . Elias, A. 2016

机译：针对乳腺癌中的雄激素受体：恩杂鲁胺作为一种新型乳腺癌治疗药物。

Prognostic value of androgen receptor and cathepsin D co-expression in non-metastatic triple-negative breast cancer and correlation with other biomarkers

著录项

相似文献

相关主题

期刊订阅